Eureka Forbes Intrinsic Value
EUREKAFORB • Consumer Goods
Current Stock Price
₹463.35
Primary Intrinsic Value
₹323.00
Market Cap
₹8989 Cr
-48.1%
Downside
Median Value
₹240.62
Value Range
₹139 - ₹568
Assessment
Trading Above Calculated Value
Safety Margin
-92.6%
EUREKAFORB Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹323.00 | ₹258.40 - ₹387.60 | -30.3% | EPS: ₹12.92, Sector P/E: 25x |
| Book Value Method | asset | ₹568.30 | ₹511.47 - ₹625.13 | +22.7% | Book Value/Share: ₹227.32, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹240.62 | ₹216.56 - ₹264.68 | -48.1% | Revenue/Share: ₹160.41, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹257.32 | ₹231.59 - ₹283.05 | -44.5% | EBITDA: ₹416.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹185.34 | ₹148.27 - ₹222.41 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹139.00 | ₹125.10 - ₹152.90 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹239.54 | ₹215.59 - ₹263.49 | -48.3% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹231.68 | ₹208.51 - ₹254.85 | -50.0% | ROE: 5.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹257.06 | ₹231.35 - ₹282.77 | -44.5% | EPS: ₹12.92, BVPS: ₹227.32 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
EUREKAFORB Intrinsic Value Analysis
What is the intrinsic value of EUREKAFORB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Eureka Forbes (EUREKAFORB) is ₹240.62 (median value). With the current market price of ₹463.35, this represents a -48.1% variance from our estimated fair value.
The valuation range spans from ₹139.00 to ₹568.30, indicating ₹139.00 - ₹568.30.
Is EUREKAFORB undervalued or overvalued?
Based on our multi-method analysis, Eureka Forbes (EUREKAFORB) appears to be trading above calculated value by approximately 48.1%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.82 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 5.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.49x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Eureka Forbes
Additional stock information and data for EUREKAFORB
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹246 Cr | ₹162 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹195 Cr | ₹179 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹181 Cr | ₹168 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹37 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |